Global seroprevalence and factors associated with seropositivity for feline immunodeficiency virus (FIV) in cats: A systematic review and meta-analysis
José Artur Brilhante Bezerra , Clécio Henrique Limeira , Ana Carolina Pontes de Miranda Maranhão , João Marcelo Azevedo de Paula Antunes , Sérgio Santos de Azevedo
{"title":"Global seroprevalence and factors associated with seropositivity for feline immunodeficiency virus (FIV) in cats: A systematic review and meta-analysis","authors":"José Artur Brilhante Bezerra , Clécio Henrique Limeira , Ana Carolina Pontes de Miranda Maranhão , João Marcelo Azevedo de Paula Antunes , Sérgio Santos de Azevedo","doi":"10.1016/j.prevetmed.2024.106315","DOIUrl":null,"url":null,"abstract":"<div><p>The feline immunodeficiency virus (FIV) is a retrovirus of the <em>Lentivirus</em> genus, distributed worldwide, that causes persistent infection with a significant impact on the cats’ health. Due to the importance of this infection in feline medicine, this pioneering study aimed to obtain an integrated estimate of the global seroprevalence of FIV in cats and to characterize the factors associated with this infection. Four electronic databases were screened for observational studies with FIV seroprevalence in cats published globally for this systematic review and meta-analysis. The initial search method returned 873 studies, of which 113 met all predefined criteria and were therefore included in this review. Meta-analysis with general data was performed, and a combined global seropositivity of 9.43 % (95 % CI: 8.24 % – 10.78 %) was found. Seropositivity was 14.34 % (95 % CI = 10.92 % – 18.61 %) in Asia, 11.90 % (95 % CI = 9.82 % – 14.34 %) in Oceania, 10.90 % (95 % CI = 5.71 % – 19.82 %) in Central America, 9.43 % (95 % CI = 6.95 % – 12.66 %) in South America, 9 % (95 % CI = 0 – 80 %) in Africa, 8.98 % (95 % CI = 7.31 % – 10.98 %) in Europe, and 5.93 % (95 % CI = 4.33 % – 8.07 %) in North America. Meta-analysis of factors associated with seropositivity demonstrated that FIV seroprevalence was higher in male (Prevalence ratio [PR] = 2.53, 95 % CI = 2.16 – 2.95), adult (PR = 2.83, 95 % CI = 2.24 – 3.56), unowned status (PR = 1.47, 95 % CI = 1.07 – 2.03), sick status (PR = 2.46, 95 % CI = 1.97 – 3.06), and cats with outdoor access (PR = 4.38, 95 % CI = 2.26 – 8.47). The results demonstrated that FIV is globally distributed and has a high seroprevalence in some geographical areas. Information compiled from this research is relevant to understanding the worldwide epidemiology of FIV. It presents the potential to contribute to the planning of strategies focused on controlling and reducing cases in cat populations.</p></div>","PeriodicalId":20413,"journal":{"name":"Preventive veterinary medicine","volume":"231 ","pages":"Article 106315"},"PeriodicalIF":2.2000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preventive veterinary medicine","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167587724002010","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The feline immunodeficiency virus (FIV) is a retrovirus of the Lentivirus genus, distributed worldwide, that causes persistent infection with a significant impact on the cats’ health. Due to the importance of this infection in feline medicine, this pioneering study aimed to obtain an integrated estimate of the global seroprevalence of FIV in cats and to characterize the factors associated with this infection. Four electronic databases were screened for observational studies with FIV seroprevalence in cats published globally for this systematic review and meta-analysis. The initial search method returned 873 studies, of which 113 met all predefined criteria and were therefore included in this review. Meta-analysis with general data was performed, and a combined global seropositivity of 9.43 % (95 % CI: 8.24 % – 10.78 %) was found. Seropositivity was 14.34 % (95 % CI = 10.92 % – 18.61 %) in Asia, 11.90 % (95 % CI = 9.82 % – 14.34 %) in Oceania, 10.90 % (95 % CI = 5.71 % – 19.82 %) in Central America, 9.43 % (95 % CI = 6.95 % – 12.66 %) in South America, 9 % (95 % CI = 0 – 80 %) in Africa, 8.98 % (95 % CI = 7.31 % – 10.98 %) in Europe, and 5.93 % (95 % CI = 4.33 % – 8.07 %) in North America. Meta-analysis of factors associated with seropositivity demonstrated that FIV seroprevalence was higher in male (Prevalence ratio [PR] = 2.53, 95 % CI = 2.16 – 2.95), adult (PR = 2.83, 95 % CI = 2.24 – 3.56), unowned status (PR = 1.47, 95 % CI = 1.07 – 2.03), sick status (PR = 2.46, 95 % CI = 1.97 – 3.06), and cats with outdoor access (PR = 4.38, 95 % CI = 2.26 – 8.47). The results demonstrated that FIV is globally distributed and has a high seroprevalence in some geographical areas. Information compiled from this research is relevant to understanding the worldwide epidemiology of FIV. It presents the potential to contribute to the planning of strategies focused on controlling and reducing cases in cat populations.
期刊介绍:
Preventive Veterinary Medicine is one of the leading international resources for scientific reports on animal health programs and preventive veterinary medicine. The journal follows the guidelines for standardizing and strengthening the reporting of biomedical research which are available from the CONSORT, MOOSE, PRISMA, REFLECT, STARD, and STROBE statements. The journal focuses on:
Epidemiology of health events relevant to domestic and wild animals;
Economic impacts of epidemic and endemic animal and zoonotic diseases;
Latest methods and approaches in veterinary epidemiology;
Disease and infection control or eradication measures;
The "One Health" concept and the relationships between veterinary medicine, human health, animal-production systems, and the environment;
Development of new techniques in surveillance systems and diagnosis;
Evaluation and control of diseases in animal populations.